We performed a correlation analysis between clinical data and model genes and found that HELLS, TOP3A, BUB3, and GTF2H4 were significantly positively correlated with clinical T and N stages of PRAD (Fig. 4A, B). The gene discussed is GTF2H4; the disease is prostate adenocarcinoma.